Table 1.
Characteristics | PLWHA receiving HAART (n = 19280) | PLWHA not receiving HAART (n = 6978) | P value |
---|---|---|---|
Age, yr | |||
Mean ± SD | 32.45 (10.31) | 31.88 (9.73) | <0.001 |
15–49 | 17955 (93.13) | 6599 (94.57) | <0.001 |
≥50 | 1325 (6.87) | 379 (5.43) | |
Sex | |||
Female | 1124 (5.83) | 490 (7.02) | <0.001 |
Male | 18156 (94.17) | 6488 (92.98) | |
Injecting drug uses | |||
No | 15749 (81.69) | 3773 (54.07) | <0.001 |
Yes | 3531 (18.31) | 3205 (45.93) | |
Income level | |||
Low | 10473 (54.32) | 4693 (67.25) | <0.001 |
Intermediate | 6231 (32.32) | 1842 (26.40) | |
High | 2576 (13.36) | 443 (6.35) | |
Urbanization | |||
Rural | 6009 (31.17) | 2695 (38.62) | <0.001 |
Urban | 13271 (68.83) | 4283 (61.38) | |
AIDS status | |||
No | 9034 (46.86) | 6179 (88.55) | <0.001 |
Yes | 10246 (53.14) | 799 (11.45) | |
Comorbidity | |||
Diabetes | 1040 (5.39) | 292 (4.18) | <0.001 |
Chronic kidney disease | 823 (4.27) | 224 (3.21) | <0.001 |
Congestive heart failure | 259 (1.34) | 77 (1.10) | 0.127 |
Hypertension | 2613 (13.55) | 568 (8.14) | <0.001 |
COPD | 1140 (5.91) | 206 (2.95) | <0.001 |
Cancer | 3153 (16.35) | 753 (10.79) | <0.001 |
Cerebral vascular disease | 503 (2.61) | 158 (2.26) | 0.115 |
Follow-up years | |||
Mean ± SD | 6.03 (3.86) | 4.86 (3.55) | <0.001 |
*Unless stated otherwise. PLWHA = people living with HIV/AIDS; SD = standard deviation; HAART = highly active anti-retroviral therapy; AIDS = acquired immunodeficiency syndrome; COPD = chronic obstructive pulmonary disease.